Global profiling strategies for mapping dysregulated metabolic pathways in cancer.
about
Applications of metabolomics in cancer researchUrinary proteomics and metabolomics studies to monitor bladder health and urological diseasesCancer Metabolism and Drug ResistanceApplication of metabolomics in drug resistant breast cancer researchWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesIDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in gliomaGSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and PathogenicityMacrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRMMetabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancerActivity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer.Predictive properties of plasma amino acid profile for cardiovascular disease in patients with type 2 diabetes.Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness.Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.Hypothermia activates adipose tissue to promote malignant lung cancer progression.Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-α and therapeutic targeting.Estimating relative changes of metabolic fluxes.Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathwayLow-mass-ion discriminant equation (LOME) for ovarian cancer screening.Metabolic phenotyping for monitoring ovarian cancer patients.The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas.Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity.Protein Sialylation Regulates a Gene Expression Signature that Promotes Breast Cancer Cell PathogenicityNon-invasive fecal metabonomic detection of colorectal cancerEmerging roles of lipid metabolism in cancer metastasis.Oncometabolomics in cancer research.Catabolic metabolism during cancer EMT.Identification of Transcription Factor YY1 as a Regulator of a Prostate Cancer-Specific Pathway Using Proteomic Analysis.High-Throughput Indirect Quantitation of 13C Enriched Metabolites Using 1H NMR.Effects of culture media on metabolic profiling of the human gastric cancer cell line SGC7901.Peroxisomal Dysfunction in Age-Related Diseases.Global and targeted serum metabolic profiling of colorectal cancer progression.A pathway map of glutamate metabolism.MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma.White opaque substance visualized using magnifying endoscopy with narrow-band imaging in colorectal epithelial neoplasms.Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells.A Mathematical Model for Enzyme Clustering in Glucose Metabolism.Perspectives of Reprogramming Breast Cancer Metabolism.PPARδ promotes tumor progression via activation of Glut1 and SLC1-A5 transcription.PPARα Promotes Cancer Cell Glut1 Transcription Repression.
P2860
Q24600728-5243EDF1-1C6A-48C7-A73D-510888EDCCC0Q26752864-C4A63647-4C65-471E-84AE-40955596EBFDQ26782042-DCB5163B-77BB-4B33-B9B9-7644760CFFC1Q26866291-F28B64B7-4BC4-428B-ADC8-C86EEA36DF28Q26991991-32F145D8-8F2F-44ED-B3EA-D824B3DF6F71Q26995506-21781630-2D3F-44BE-BC0C-C6179037920EQ28275543-8298E365-D25D-49CE-8A18-FA9E98D58136Q28394764-AF06BFB3-C825-44CF-A8FA-A252E8F662D1Q28609305-C2F094F7-7868-4162-9A7A-01D4A7817ABCQ30299995-FF58F00C-4E9B-4053-8EEC-56416AD0C1BDQ33817483-D7352E5A-A4FD-4C80-8003-2CC87EB9AC5FQ33824915-644B6C34-105F-4E24-972D-6955732A2189Q33993449-EBF35305-ABF5-4EE3-9D06-04A7AE766EE7Q34981346-D158F391-A853-4A10-B201-D723ABF1F881Q35244854-01A58132-4719-4174-B3B4-63572646D156Q35439820-8AF7FCD2-C32F-419D-B4E7-4304B3B41897Q35781420-AB9A340C-D5BF-463A-A21D-E9285BA1BD2BQ36165662-D43797BD-90FB-4B90-A5F6-6BA11F9F7DBBQ36708032-79D1BC6C-DFFF-4EFD-A934-9B44E8B4381FQ36955557-2DE929E5-E539-4679-B12F-CA580C0D95ACQ37050321-39268C4D-124A-408C-85DA-7681B8AECBC0Q37173034-1A8886B5-E9B2-4CF8-B641-415178650AEEQ37195656-7626CC77-0BE6-49CD-86FD-7F9FFCBED63AQ37692448-1A022417-CCA6-4836-8735-3E2FDA9ABBC7Q37747513-4F93B7A0-5EE9-42AA-B743-5B511ADCA7B5Q38132912-02AD7162-E5CA-42CE-92B4-F60BC79C155EQ38336993-4201983A-8DD3-4D29-B6F3-E6C81FE71239Q38399742-0392E859-ED06-4742-9B58-180BE4136DB6Q38740625-5B0934FC-52A6-4AD8-BC2A-442B9643144EQ38880778-7C4D1E47-EEBF-4C8F-AD36-7C937C8FD5FCQ39073343-9251578A-A59B-43A7-8962-12DCB9B90DA8Q40149592-37AC39F6-B4AB-4DBA-AF45-11D839CC0299Q40784506-19CF0B72-BB24-495A-B507-05DCD1212EF4Q41316559-BDE9CE17-AF3E-4440-8159-46C83DDF9A7CQ45127320-09843563-E437-4570-8881-DE67EF021C5DQ48237710-ACA94287-1B07-43D1-A921-8CB808B99D09Q49217648-22C1B4AD-909A-4BF8-BEB0-20793C97651AQ49544341-785783F5-B051-4E76-922A-126738273B50Q50656567-530975DF-42E0-4F39-96AF-CD6B788C3C41Q51285461-2B957EB7-707C-4A51-8A61-45D00DCFF4C1
P2860
Global profiling strategies for mapping dysregulated metabolic pathways in cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Global profiling strategies for mapping dysregulated metabolic pathways in cancer.
@ast
Global profiling strategies for mapping dysregulated metabolic pathways in cancer.
@en
type
label
Global profiling strategies for mapping dysregulated metabolic pathways in cancer.
@ast
Global profiling strategies for mapping dysregulated metabolic pathways in cancer.
@en
prefLabel
Global profiling strategies for mapping dysregulated metabolic pathways in cancer.
@ast
Global profiling strategies for mapping dysregulated metabolic pathways in cancer.
@en
P2860
P1433
P1476
Global profiling strategies for mapping dysregulated metabolic pathways in cancer.
@en
P2093
Daniel I Benjamin
Daniel K Nomura
P2860
P304
P356
10.1016/J.CMET.2012.09.013
P577
2012-10-11T00:00:00Z